Location History:
- Viby J, DK (2006)
- Viby, DK (2006 - 2019)
- Højbjerg, DK (2022)
Company Filing History:
3 out of 3 
2 out of 60 
1 out of 1,746 
Years Active: 2006-2022
Title: Innovator Claus Oxvig and His Contributions to the Field of Biomedicine
Introduction
Claus Oxvig is a prominent inventor based in Viby, Denmark, known for his significant contributions to the field of biomedicine. With a portfolio of 6 patents, Oxvig has made notable advancements that have the potential to impact the treatment of various clinical conditions.
Latest Patents
Among his latest innovations is the Pappalysin regulator, which outlines a method for modulating the activity of a Pappalysin polypeptide through the manipulation of interacting polypeptides. This method can be utilized in preventing, treating, or ameliorating clinical conditions in mammals, including humans, by administering effective amounts of stanniocalcin polypeptides or agents that antagonize their interaction with Pappalysin polypeptides. Another patented invention is focused on Pregnancy-associated plasma protein-A2 (PAPP-A2), providing essential sequences, antibodies, and screening methods for pathologies in both pregnant and non-pregnant individuals. This invention expands on the understanding of PAPP-A2 and its relevance in monitoring altered focal proliferation states.
Career Highlights
Claus Oxvig has had an impactful career, collaborating with leading organizations in biomedicine. His tenure at Como Biotech Aps and Aarhus Universitet has enabled him to develop innovative solutions aimed at improving healthcare outcomes.
Collaborations
Throughout his career, Claus Oxvig has partnered with notable professionals, including Michael Toft Overgaard and Jakob Hauge Mikkelsen. These collaborations have fostered a collaborative spirit that is vital for driving advancements in scientific research and innovation.
Conclusion
Claus Oxvig continues to be a significant figure in the realm of biomedicine, with his inventions poised to enhance clinical practices. His work reflects the importance of innovation in addressing health-related challenges, ultimately contributing to improved patient care and treatment options.